Thursday, Cell Therapeutics Inc. (CTIC) said its third-quarter net loss attributable to common shareholders widened to $48.8 million from $47.6 million in the prior year period. Loss per share for the quarter narrowed to $0.09 per share from $2.83 per share in the year-ago period.
Total revenues for the quarter plunged to $20 thousand from $2.60 million in the comparable period.
For comments and feedback: editorial@rttnews.com